|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Diabetes Research Center, Division of Endocrinology, Cincinnati Children's Hospital Research Foundation and College of Medicine, Cincinnati, OH, USA
2 Division of Pediatric Informatics, Cincinnati Children's Research Foundation and College of Medicine, Cincinnati, OH, USA
3 Division of Pediatric Informatics, Cincinnati Children's Research Foundation and College of Medicine, Cincinnati, OH, USA; Division of Developmental Biology, Cincinnati Children's Hospital Research Foundation and College of Medicine, Cincinnati, OH, USA
4 Diabetes Research Center, Division of Endocrinology, Cincinnati Children's Hospital Research Foundation and College of Medicine, Cincinnati, OH, USA; Division of Molecular Immunology, Cincinnati Children's Hospital Research Foundation and College of Medicine, Cincinnati, OH, USA
* To whom correspondence should be addressed. E-mail: jonathan.katz{at}cchmc.org.
In Type I diabetes mellitus (T1DM), also known as autoimmune diabetes, the pathogenic destruction of the insulin producing pancreatic beta cells is under the control of and influenced by distinct subsets of T lymphocytes. To identify the critical genes expressed by autoimmune T cells, antigen presenting cells and pancreatic beta cells during the evolution of T1DM in the NOD mouse, and the genetically-altered NOD mouse (BDC/N), we used functional genomics. Microarray analysis revealed increased transcripts of genes encoding inflammatory cytokines, particularly interleukin (IL)-17, and islet cell regenerating genes - Reg 3
, Reg3
and Reg3
. Our data indicate that progression to insulitis was connected to marked changes in islet antigen expression, beta cell differentiation and T cell activation and signaling - all associated with tumor necrosis factor-
and IL-6 expression. Overt diabetes saw a clear shift in cytokine, chemokine and T cell differentiation factor expression, consistent with a focused Th1 response, as well as a significant upregulation in genes associated with cellular adhesion, homing and apoptosis. Importantly, the temporal pattern of expression of key verified genes suggested that T1DM develops in a relapsing/remitting as opposed to a continuous fashion, with insulitis linked to hypoxia-regulated gene control and diabetes with C/EBP and Nkx2 gene control.
This article has been cited by other articles:
![]() |
G. Cui, X. Qin, Y. Zhang, Z. Gong, B. Ge, and Y. Q. Zang Berberine Differentially Modulates the Activities of ERK, p38 MAPK, and JNK to Suppress Th17 and Th1 T Cell Differentiation in Type 1 Diabetic Mice J. Biol. Chem., October 9, 2009; 284(41): 28420 - 28429. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Emamaullee, J. Davis, S. Merani, C. Toso, J. F. Elliott, A. Thiesen, and A.M. J. Shapiro Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice Diabetes, June 1, 2009; 58(6): 1302 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Akirav, J. A. Kushner, and K. C. Herold {beta}-Cell Mass and Type 1 Diabetes: Going, Going, Gone? Diabetes, November 1, 2008; 57(11): 2883 - 2888. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sgouroudis, A. Albanese, and C. A. Piccirillo Impact of Protective IL-2 Allelic Variants on CD4+Foxp3+ Regulatory T Cell Function In Situ and Resistance to Autoimmune Diabetes in NOD Mice J. Immunol., November 1, 2008; 181(9): 6283 - 6292. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Spolski, M. Kashyap, C. Robinson, Z. Yu, and W. J. Leonard IL-21 signaling is critical for the development of type I diabetes in the NOD mouse PNAS, September 16, 2008; 105(37): 14028 - 14033. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Venkatachalam, S. Mummidi, D. M. Cortez, S. D. Prabhu, A. J. Valente, and B. Chandrasekar Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2078 - H2087. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Geoffrey, S. Jia, A. E. Kwitek, J. Woodliff, S. Ghosh, A. Lernmark, X. Wang, and M. J. Hessner Evidence of a Functional Role for Mast Cells in the Development of Type 1 Diabetes Mellitus in the BioBreeding Rat J. Immunol., November 15, 2006; 177(10): 7275 - 7286. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis J. Immunol., July 1, 2006; 177(1): 566 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liang and B. Ventura Physiological genomics in PG and beyond: October to December 2005 Physiol Genomics, December 14, 2005; 24(1): 1 - 3. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |